Press Releases Ascelia Pharma AB

Equities

ACE

SE0010573113

Market Closed - Nasdaq Stockholm Other stock markets 11:29:50 2024-04-26 am EDT			5-day change	1st Jan Change
11.16 ^SEK	+5.28%		-15.33%	+231.16%

Apr. 10	Ascelia Pharma Reports SPARKLE Image Reading Completion and Expects Headline Results First Half of May 2024	CI
Feb. 09	Ascelia Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ascelia Pharma Draws Down SEK 15 Million Second Tranche Under Existing Loan Facility	Apr. 18	AQ
Ascelia Pharma Reports SPARKLE Image Reading Completion and Expects Headline Results First Half of May 2024	Apr. 10	AQ
Annual Report 2023: Solid Progress with Orviglance Phase 3 Patient Recruitment Completed and Headline Results Expected by May 2024	Apr. 08	AQ
Notice of Annual General Meeting in Ascelia Pharma AB	Mar. 27	AQ
Ascelia Pharma Q4 2023 - On track with easing financial pressure	Feb. 12	AQ
Q4 and Full Year Report 2023: Strengthened Financial Position Ahead of SPARKLE Phase 3 Study Headline Results in May	Feb. 09	AQ
Ascelia Pharma Secures Financing of up to SEK 35 Million	Feb. 04	AQ
Orviglance Review Article Published in Investigative Radiology	Jan. 24	AQ
Nomination Committee Appointed for AGM 2024 in Ascelia Pharma AB	Jan. 24	AQ
Ascelia Pharma Announces Start of Image Reading Phase and Re-confirms Phase 3 SPARKLE Results by May 2024	Dec. 07	AQ
Change in Number of Shares and Votes in Ascelia Pharma AB	Nov. 30	AQ
Bulletin from the Extraordinary General Meeting in Ascelia Pharma AB on 13 November 2023	Nov. 13	AQ
Ascelia Pharma resolves on conversion of series C shares into ordinary shares for delivery to participants in incentive program	Nov. 09	AQ
QUARTERLY REPORT Q3 2023: Re-evaluation of SPARKLE Phase 3 Study Images Progresses According to Plan	Nov. 08	AQ
OptiCept Technologies recruits a new CFO	23-10-20	AQ
NOTICE OF EXTRAORDINARY GENERAL MEETING IN ASCELIA PHARMA AB	23-10-19	AQ
Ascelia Pharma Gets Acceptance for Publication of Orviglance Review Article in Investigative Radiology	23-10-04	AQ
Ascelia Pharma - All attention on the top priority	23-09-18	AQ
Ascelia Pharma to Reach Headline Results from SPARKLE Re-Evaluation by May 2024 with Current Funding	23-09-13	AQ
Ascelia Pharma significantly reduces organization to reach SPARKLE headline results	23-08-31	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Ascelia Pharma AB

Equities

ACE

SE0010573113

Press Releases

Filters